- Trials with a EudraCT protocol (1,221)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (348)
1,221 result(s) found for: Adolescents.
Displaying page 1 of 62.
EudraCT Number: 2016-000367-16 | Sponsor Protocol Number: 0305070106 | Start Date*: 2017-03-23 |
Sponsor Name:Radboud University Nijmegen | ||
Full Title: The effect of oxytocin administration on empathy and emotion recognition in healthy and antisocial adolescents | ||
Medical condition: We examine the effect of oxytocin administration on empathy and emotion recognition in healthy adolescents and adolescents with antisocial behavior and history of severe psychological trauma | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005086-20 | Sponsor Protocol Number: CHDR1117 | Start Date*: 2011-11-22 |
Sponsor Name:Centre for Human Drug Research (CHDR) | ||
Full Title: Effects of paracetamol on nociception in adolescents. | ||
Medical condition: Nociceptive pain (disorders) | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-000404-37 | Sponsor Protocol Number: LP0133-1181 | Start Date*: 2021-04-14 |
Sponsor Name:LEO Pharma A/S | ||
Full Title: A phase 1 open-label, multi-centre, single-arm trial to evaluate the safety and pharmacokinetics (including MUsT) of twice daily topical application of delgocitinib cream for 8 weeks in adults, ado... | ||
Medical condition: Atopic Dermatitis (AD) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2010-023980-17 | Sponsor Protocol Number: Metformin 3.0 | Start Date*: 2011-08-24 |
Sponsor Name:St. Antonius Hospital | ||
Full Title: An efficacy, safety and pharmacokinetic study on the short-term and long-term use of METFORMIN in obese children and adolescents | ||
Medical condition: obese children and adolescents of Caucasian descent with insulin resistance in the age of ≥ 10 and ≤ 16 years at study entry. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016924-30 | Sponsor Protocol Number: NorCAPITAL | Start Date*: Information not available in EudraCT |
Sponsor Name:Division of Paediatrics, Rikshospitalet University Hospital | ||
Full Title: NorCAPITAL The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial | ||
Medical condition: Chronic fatigue syndrom/myalgic encephalomyelitis (CFS/ME) in adolescents | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004443-40 | Sponsor Protocol Number: CFAM810B2305 | Start Date*: 2016-04-12 |
Sponsor Name:Novartis Pharmaceuticals | ||
Full Title: A Multicenter, Open-label, Single-arm Study to Evaluate the Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis | ||
Medical condition: Herpes Labialis | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2017-003220-78 | Sponsor Protocol Number: I8B-MC-ITSA | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Children, Adolescents, and Adults with Type 1 Diabetes Mellitus | |||||||||||||
Medical condition: Diabetes Mellitus, Type 1 | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000844-81 | Sponsor Protocol Number: MS306 | Start Date*: 2019-05-31 |
Sponsor Name:Ipsen Pharma | ||
Full Title: RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-1 (rhIGF-1) TREATMENT OF CHILDREN AND ADOLESCENTS WITH GROWTH FAILURE ASSOCIATED WITH PRIMARY IGF-1 DEFICIENCY: AN OPEN-LABEL, MULTI-CENTER, EXTENSION S... | ||
Medical condition: Children and adolescents with growth failure associated with primary insulin-like growth factor deficiency (IGFD). | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-004659-30 | Sponsor Protocol Number: PKM6270 | Start Date*: 2015-03-17 |
Sponsor Name:sanofi-aventis | ||
Full Title: Four-week, open-label, multicenter, randomized, parallel-group study to investigate the pharmacokinetics, safety, tolerability and the effects on leak point pressure of 2 oral doses of alfuzosin (0... | ||
Medical condition: Urinary Bladder Neurogenic | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2006-002738-39 | Sponsor Protocol Number: 04-7-011 | Start Date*: 2006-09-22 | |||||||||||
Sponsor Name:Astelleas Pharma US, Inc. | |||||||||||||
Full Title: A Phase 1 Open-Label Study of the Pharmacokinetics of Tacrolimus Cream B 0.1% after Twice Daily Topical Administration in Adolescents (≥ 12 to ≤ 17 Years of Age ) with Psoriasis | |||||||||||||
Medical condition: Determination of pharmacokinetics and safety of tacrolimus in adolescents with plaque psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000175-86 | Sponsor Protocol Number: CN138-180 | Start Date*: 2017-04-07 |
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, | ||
Full Title: A 52-Week, Open-label, Multicenter Study of the Safety and Tolerability of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents with Autistic Disorder | ||
Medical condition: Autistic disorder | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2005-003129-23 | Sponsor Protocol Number: 04/MR/111 | Start Date*: 2006-04-18 |
Sponsor Name:Belfast Health and Social Care Trust, Musgrave Park Hospital | ||
Full Title: Prevention and Treatment of Steroid-Induced Osteopenia in children and adolescents with rheumatic diseases | ||
Medical condition: Children and adolescents with Juvenile Idiopathic arthritis (JIA), Juvenile dermatomyositis (JDMS) Juvenile systemic lupus erythematosis (JSLE) Vasculitis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001029-30 | Sponsor Protocol Number: PENTA22-Viiv212968 | Start Date*: 2021-08-11 | |||||||||||
Sponsor Name:Fondazione Penta ONLUS | |||||||||||||
Full Title: A multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in HIV-1 infected c... | |||||||||||||
Medical condition: HIV-1 infection in children and adolescents with Multi Drug-Resistant virus | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004732-11 | Sponsor Protocol Number: | Start Date*: 2018-01-19 |
Sponsor Name:University of Oxford | ||
Full Title: Preventing meningitis in young people after infant immunisation: effect of a single meningococcal 4CMenB vaccine booster over 10 years of age | ||
Medical condition: Meningococcus group B disease, which can cause a variety of symptoms. The most serious of these are meningitis, and septicaemia (also known as blood poisoning). | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001048-24 | Sponsor Protocol Number: NN7769-4514 | Start Date*: 2021-05-18 | ||||||||||||||||
Sponsor Name:Novo Nordisk A/S | ||||||||||||||||||
Full Title: A multinational, open-label, randomised, controlled trial to investigate efficacy and safety of NNC0365-3769 (Mim8) in adults and adolescents with haemophilia A with or without inhibitors. | ||||||||||||||||||
Medical condition: Haemophilia A Haemophilia A with inhibitors | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IE (Ongoing) SK (Ongoing) DK (Ongoing) DE (Ongoing) BE (Completed) AT (Ongoing) LV (Ongoing) LT (Ongoing) NL (Ongoing) PL (Ongoing) PT (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013131-38 | Sponsor Protocol Number: 820903 | Start Date*: 2009-08-13 | |||||||||||
Sponsor Name:Baxter Innovations GmbH | |||||||||||||
Full Title: An open label phase 1/2 study to assess the immunogenicity and safety of two different dose levels of H1N1 pandemic infuenza vaccine in healthy infants, children and adolescents aged 6 months to 17... | |||||||||||||
Medical condition: A/H1N1, Immunogenicity and Safety in Infants, Children and Adolescents, aged 6 months to 17 Years | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005510-20 | Sponsor Protocol Number: C10953/1100 | Start Date*: 2013-03-07 |
Sponsor Name:Cephalon, Inc. | ||
Full Title: A Randomized, Open-Label Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Single and Multiple Doses of Armodafinil (50, 100, and 150 mg/day) in Children and Adolescents w... | ||
Medical condition: Excessive Sleepiness associated with Narcolepsy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-018518-56 | Sponsor Protocol Number: E2007-G000-235 | Start Date*: 2010-10-11 |
Sponsor Name:Eisai Limited | ||
Full Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and ... | ||
Medical condition: Inadequately controlled partial onset seizures | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: LV (Completed) ES (Completed) BE (Completed) HU (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-003881-38 | Sponsor Protocol Number: ESONIA | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Warszawski Uniwersytet Medyczny | |||||||||||||
Full Title: ESONIA - The evaluation of Efficacy and Safety Of Nebivolol in the treatment of arterial hypertension In Adolescents | |||||||||||||
Medical condition: Arterial hypertension in adolescents | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003737-29 | Sponsor Protocol Number: BUU-5/EEA | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Dr. Falk Pharma GmbH | |||||||||||||
Full Title: Double-blind, randomized, placebo-controlled, Phase II/III trial on the efficacy and tolerability of treatment with budesonide oral suspension vs. placebo in children and adolescents with eosinophi... | |||||||||||||
Medical condition: Active eosinophilic esophagitis and maintenance of remission in eosinophilic esophagitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) PT (Completed) NL (Completed) GR (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.